Faculty Profile

Tien Truong
Section of Hematology / Oncology
Instructor of Medicine

Academic Interests

Dr. Troung's research focuses on exploring the role of broad preemptive pharmacogenomic testing and implementing pharmacogenomic information into routine clinical practice in achieving personalized care.She helped launch the ‘ImPreSS Trial’, a study examining pharmacogenomic implementation to guide medication decision-making in the perioperative care setting to optimize outcomes for patients with elective surgeries. She will also be leading the development of the Personalized Therapeutics Clinic (PTC) to provide genotyping and consultation services in the outpatient setting, which will provide a platform to explore other research questions surrounding pharmacogenomics, patient-provider communication, and medication adherence. She pioneered the development of the YourPGx Portal, a secured web tool that provides pharmacogenomic results and information to patients. Together with the PTC, this patient portal will allow her to explore the impact of providing patients with their genotyping test results and education to empower them to be more active in managing their own healthcare. Her goal is to study the role of pharmacogenomics in various disease states, including hematology and oncology, pain and palliative care, infectious disease, and cardiology.

Clinical Interests

Pharmacogenomics and precision medicine


  • Tien M Truong, Jeffrey Apfelbaum, Sajid Shahul, Magdalena Anitescu, Keith Danahey, Randall W Knoebel, David Liebovitz,Theodore Karrison, Xander M R van Wijk, Kiang-Teck J Yeo,David Meltzer, Mark J Ratain, Peter H O'Donnell. The ImPreSS Trial: Implementation of Point-of-Care Pharmacogenomic Decision Support in Perioperative Care. Clin Pharmacol Ther. 2019 Dec; 106(6): 1179–1183.
  • Tien M Truong, Elizabeth Lipschultz, Keith Danahey, Emily Schierer, Mark J Ratain, Peter H O'Donnell. Assessment of Patient Knowledge and Perceptions of Pharmacogenomics Before and After Using a Mock Results Patient Web Portal. Clin Transl Sci. 2020 Jan; 13(1): 78–87


  • BS, 2008, Universitsy of Virginia, Biology
  • Pharm.D., 2016, Virginia Commonwealth University,
  • PhD, 2016, Virginia Commonwealth University,
  • Fellowship, 2020, University of Chicago, Committee on Clinical Pharmacology and Pharmacogenomics